Hofseth Biocare ASA
OSE:HBC

Watchlist Manager
Hofseth Biocare ASA Logo
Hofseth Biocare ASA
OSE:HBC
Watchlist
Price: 1.86 NOK 0.27%
Market Cap: 734.9m NOK
Have any thoughts about
Hofseth Biocare ASA?
Write Note

Gross Margin
Hofseth Biocare ASA

27.7%
Current
26%
Average
63.7%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
27.7%
=
Gross Profit
66.5m
/
Revenue
239.9m

Gross Margin Across Competitors

Country Company Market Cap Gross
Margin
NO
Hofseth Biocare ASA
OSE:HBC
764.6m NOK
28%
FR
Pharnext SCA
OTC:PNEXF
6T USD
0%
US
Abbvie Inc
NYSE:ABBV
315.4B USD
67%
US
Amgen Inc
NASDAQ:AMGN
142B USD
60%
US
Gilead Sciences Inc
NASDAQ:GILD
111.1B USD
78%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
106.2B USD
86%
US
Epizyme Inc
F:EPE
94.1B EUR
76%
AU
CSL Ltd
ASX:CSL
138.7B AUD
52%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.8B USD
87%
US
Seagen Inc
F:SGT
39.3B EUR
75%
NL
argenx SE
XBRU:ARGX
38.4B EUR
89%
Country NO
Market Cap 764.6m NOK
Gross Margin
28%
Country FR
Market Cap 6T USD
Gross Margin
0%
Country US
Market Cap 315.4B USD
Gross Margin
67%
Country US
Market Cap 142B USD
Gross Margin
60%
Country US
Market Cap 111.1B USD
Gross Margin
78%
Country US
Market Cap 106.2B USD
Gross Margin
86%
Country US
Market Cap 94.1B EUR
Gross Margin
76%
Country AU
Market Cap 138.7B AUD
Gross Margin
52%
Country US
Market Cap 80.8B USD
Gross Margin
87%
Country US
Market Cap 39.3B EUR
Gross Margin
75%
Country NL
Market Cap 38.4B EUR
Gross Margin
89%
No Stocks Found

Hofseth Biocare ASA
Glance View

Market Cap
764.6m NOK
Industry
Biotechnology

Hofseth Biocare ASA engages in the development, marketing, and sale of biomarine ingredients. The company is headquartered in Alesund, More Og Romsdal and currently employs 63 full-time employees. The company went IPO on 2011-12-02. The Company’s business is development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. Its main products are Salmon protein hydrolysate (ProGo), which is a protein for sports, endurance, and recovery powders; Fresh, all-natural salmon oil (OmeGo) that has a full spectrum of omega fatty acids, including EPA, DHA and DPA, totaling 21 different fatty acids; Calcium bone powder (CalGo) is a natural marine collagenic bone powder and CollaGo is a Collagen Peptide powder optimised to improve the beauty of hair, skin and nails. Hofseth BioCare's headquarters are in Aalesund with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.

HBC Intrinsic Value
4.17 NOK
Undervaluation 55%
Intrinsic Value
Price
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
27.7%
=
Gross Profit
66.5m
/
Revenue
239.9m
What is the Gross Margin of Hofseth Biocare ASA?

Based on Hofseth Biocare ASA's most recent financial statements, the company has Gross Margin of 27.7%.